| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.79 | 0.002 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |